Quantum-Si Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing Platform
QSI Stock | USD 1.14 0.09 7.32% |
Under 57% of QuantumSi's investor base is looking to short. The analysis of the overall investor sentiment regarding QuantumSi suggests that many traders are alarmed. QuantumSi's investing sentiment shows overall attitude of investors towards QuantumSi.
QuantumSi |
Quantum-Si Incorporated , The Protein Sequencing Company, today announced the launch of new platf
Read at businesswire.com
QuantumSi Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards QuantumSi can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
QuantumSi Fundamental Analysis
We analyze QuantumSi's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of QuantumSi using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of QuantumSi based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
QuantumSi is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
QuantumSi Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with QuantumSi stock to make a market-neutral strategy. Peer analysis of QuantumSi could also be used in its relative valuation, which is a method of valuing QuantumSi by comparing valuation metrics with similar companies.
Peers
QuantumSi Related Equities
CRBU | Caribou Biosciences | 8.91 | ||||
VERV | Verve Therapeutics | 8.85 | ||||
HOOK | Hookipa Pharma | 6.90 | ||||
HRTX | Heron Therapeuti | 5.45 | ||||
BEAM | Beam Therapeutics | 5.26 | ||||
BDTX | Black Diamond | 4.05 | ||||
NTLA | Intellia Therapeutics | 3.26 | ||||
CRSP | Crispr Therapeutics | 3.10 | ||||
ABOS | Acumen Pharmaceuticals | 2.73 | ||||
SEER | Seer | 0.81 | ||||
EDIT | Editas Medicine | 0.45 | ||||
ALEC | Alector | 0.78 | ||||
RNA | Avidity Biosciences | 1.07 | ||||
PRME | Prime Medicine, | 1.20 | ||||
NRIX | Nurix Therapeutics | 2.57 | ||||
MNOV | MediciNova | 3.37 | ||||
HCWB | HCW Biologics | 10.34 | ||||
PASG | Passage Bio | 11.12 |
Complementary Tools for QuantumSi Stock analysis
When running QuantumSi's price analysis, check to measure QuantumSi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy QuantumSi is operating at the current time. Most of QuantumSi's value examination focuses on studying past and present price action to predict the probability of QuantumSi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move QuantumSi's price. Additionally, you may evaluate how the addition of QuantumSi to your portfolios can decrease your overall portfolio volatility.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |